For the second quarter of 2026 management expects year-over-year consolidated revenues to decline 4%-6%, consensus $2.09B, with adjusted EBITDA expected to be between $185M-$215M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOV:
- Is NOV a Buy, Before Earnings?
- NOV: Near-Term Earnings Headwinds and Competitive Disadvantages Justify Hold Rating Despite Late-Cycle Upside Potential
- NOV: Middle East Disruptions, Margin Pressure, and Limited Upside Drive Sell Rating
- Midday Fly By: BofA, Morgan Stanley beat expectations in Q1
- NOV Inc. sees Q1 revenue, earnings below prior guidance